Search Results for 'inhibitors cancer'
inhibitors cancer published presentations and documents on DocSlides.
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
by min-jolicoeur
CDK 4/6 Inhibitors in Breast Cance...
Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer
by min-jolicoeur
This program will include a discussion of off-lab...
The Use of PARP Inhibitors in Breast Cancer: Challenges
by calandra-battersby
and Opportunities. This program will include a di...
Oestrogen attaches to receptors in breast cancer cells enabling the c
by cecilia
tablet the next day.Aromatase inhibitors can inter...
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
by yoshiko-marsland
Pan Tumors. This program will include a discussio...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
by calandra-battersby
An Interactive Oncology Grand Rounds Series. Joyc...
Osteoclast Inhibitors in Malignancy
by onionchevrolet
Joel Brothers. 10/4/2016. Understand the indicatio...
The use of immune checkpoint inhibitors to treat many different types of cancers has increased dram
by joyce
Recognizing an opportunity for improvement in the ...
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
by leah
Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
Comparative effect of Various HDAC-inhibitors in-vitro on T
by pasty-toler
lines . alone and in combination with convention...
What’s Positive about Triple Negative Breast Cancer
by myesha-ticknor
What’s Positive about Triple Negative Breast Ca...
Targeting endocrine-resistance pathways in breast cancer
by alexa-scheidler
Targeting endocrine-resistance pathways in breas...
Immunotherapy for advanced cervical cancer
by elizabeth
Megan Swanson, MD MPH. Assistant Professor. Gyneco...
Oncology Basics CANCER TREATMENT MODALITIES
by angelina
Mohammed A. Suwaid, MD. Board-certified Medical On...
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Oncology Technologies at the University of Chicago
by mary
May 2019. Available Oncology Technologies. 2. Onc...
Targeting DNA repair for anticancer therapy Thomas Helleday12 Cec
by elina
ABSTRACT Chemotherapy often targets dividing cells...
rozoleFemaraHormonal TherapyInformation for Patients and Families
by barbara
��Letrozole(Breast)��U...
National Lynch Syndrome project Team Update
by okelly
Sarah John and Siobhan John . SWGMSA Nurse facilit...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Transforming treatment and improving survival for
by olivia-moreira
ovarian cancer patients. Laura Shawver, PhD. Foun...
CardioOncology : The Promise and Pitfalls of Personalized Medicine
by emmy
Vijay U. Rao, MD, PhD, FACC, FASE, FHFSA. Francisc...
Advances in Gastrointestinal Cancers
by lindy-dunigan
This program will include a discussion of data th...
Detection of Mutations in EGFR in Circulating Lung-Cancer C
by sherrill-nordquist
Colin Reisterer and Nick Swenson. S. . Maheswaran...